Xenon to Present at Wells Fargo Healthcare Conference
VANCOUVER, BC and BOSTON, MA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced that the company will present at an upcoming investor conference:
Covered in this story
What has happened since
- Wells Fargo is down 6.9% since this was published, 49 days ago.
- Xenon Pharmaceuticals Inc is down 39.6% since this was published, 49 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Wells Fargo
- Citi: $80.7 → $88 by Oct 2027 · Neutral via MarketBeat
- RBC Capital Markets: $79.9 → $92 by Oct 2027 · Outperform via TradingView
- TD Cowen: $81.6 → $95 by Oct 2027 via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $WFC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Wells Fargo →Dalsna Finance is currently tracking 51 stories mentioning Wells Fargo, the earliest published 17 Jul 2026.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.